Ilkay Yildiz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Journal of biomolecular structure & dynamics

Artificial cells, nanomedicine, and biotechnology

Molecules (Basel, Switzerland)

Ankara University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ankara University

Turkey

Prof. Dr. :: Faculty of Pharmacy, Department of Pharmaceutical Chemistry

Publications

Duangjai Todsaporn, Alexander Zubenko, Victor Kartsev, Thitinan Aiebchun, Panupong Mahalapbutr, Petrou Anthi, Geronikaki Athina, Lyudmila N Divaeva, Victoria Chekrisheva, Ilkay Yildiz, Kiattawee Choowongkomon, Thanyada Rungrotmongkol
Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study. Molecules (Basel, Switzerland) 28 (7) (2023)
Gozde Yalcin-Ozkat, Ronak H Ersan, Mahmut Ulger, Seda T Ulger, Serdar Burmaoglu, Ilkay Yildiz, Oztekin Algul
Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents. Journal of biomolecular structure & dynamics (2022)
Emine Oksuzoglu, Serap Yilmaz, Gozde Yenice Cakmak, Sanaz Ataei, Ilkay Yildiz
Antitumor activity against human promyelocytic leukemia and in silico studies of some benzoxazines. Journal of biomolecular structure & dynamics (2022)
Zekeriya DÜzgÜn, Birgül Vanizor Kural, Asım Örem, Ilkay Yildiz
In silico investigation of the interactions of certain drugs proposed for the treatment of Covid-19 with the paraoxonase-1. Journal of biomolecular structure & dynamics (2021)
Tugba Ertan-Bolelli, Kayhan Bolelli, Yaman Musdal, Ilkay Yildiz, Esin Aki Yalcin, Bengt Mannervik, Ismail Yalcin
Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors. Artificial cells, nanomedicine, and biotechnology 46 (3) (2017)